MRNA structure, post-transcriptional modifications (cap, poly A, splicing).

From WikiLectures


Messenger RNA (mRNA) is a type of RNA that serves as the intermediate template between DNA and protein synthesis. It carries genetic information transcribed from genes and is translated by ribosomes into a specific amino acid sequence. In eukaryotes, primary mRNA (pre-mRNA) undergoes several essential **post-transcriptional modifications** before becoming a mature, translatable molecule.

Structure of mRNA[edit | edit source]

A typical eukaryotic mature mRNA molecule consists of the following regions:

  • 5′ cap – A modified guanine nucleotide added to the 5′ end.
  • 5′ untranslated region (5′ UTR) – Regulates translation initiation.
  • Coding region (ORF) – Contains codons that encode the amino acid sequence.
  • 3′ untranslated region (3′ UTR) – Involved in regulation of translation and mRNA stability.
  • Poly(A) tail – A stretch of adenine nucleotides at the 3′ end.

Post-transcriptional modifications[edit | edit source]

Eukaryotic pre-mRNA (hnRNA) undergoes the following key modifications:

1. 5′ capping[edit | edit source]

  • A 7-methylguanosine (m7G) cap is added to the 5′ end of the pre-mRNA shortly after transcription begins.
  • **Enzymes involved:**
    • RNA triphosphatase
    • Guanylyltransferase
    • Methyltransferase
  • **Functions:**
    • Protects mRNA from degradation by exonucleases.
    • Aids in ribosome binding during translation initiation.
    • Facilitates nuclear export of mRNA.

2. Polyadenylation (Poly(A) tail)[edit | edit source]

  • After transcription, ~200 adenine nucleotides are added to the 3′ end by **poly(A) polymerase**.
  • Requires cleavage of the pre-mRNA at a specific polyadenylation signal (AAUAAA).
  • **Functions:**
    • Enhances mRNA stability.
    • Promotes translation efficiency.
    • Involved in nuclear export.

3. RNA splicing[edit | edit source]

  • Removes non-coding sequences (**introns**) and joins coding sequences (**exons**).
  • Carried out by the **spliceosome**, a large complex of small nuclear RNAs (snRNAs) and proteins (snRNPs).
  • **Steps:**
  1. Spliceosome recognizes 5′ and 3′ splice sites.
  2. A lariat structure is formed from the intron.
  3. Exons are ligated, and the intron is released and degraded.
  • **Alternative splicing:**
    • Allows a single gene to code for multiple protein isoforms.
    • Increases protein diversity.

Summary table[edit | edit source]

Modification Enzyme/Complex Function
5′ capping Guanylyltransferase, methyltransferase Protects mRNA, promotes translation
Polyadenylation Poly(A) polymerase Stabilizes mRNA, aids in translation
Splicing Spliceosome (snRNPs) Removes introns, joins exons

Prokaryotic vs. eukaryotic mRNA[edit | edit source]

Feature Eukaryotic mRNA Prokaryotic mRNA
5′ cap Present Absent
Poly(A) tail Present Rare or absent
Introns Present (spliced out) Absent
Monocistronic/polysistronic Mostly monocistronic Often polycistronic

Clinical relevance[edit | edit source]

  • **Splicing errors** – Mutations at splice sites can lead to diseases such as β-thalassemia, spinal muscular atrophy, and certain cancers.
  • **mRNA vaccines** – Use modified mRNA with synthetic caps and poly(A) tails to encode antigens (e.g., COVID-19 vaccines).
  • **Cancer therapeutics** – Targeting aberrant splicing patterns is a novel strategy in oncology.

References[edit | edit source]

Related articles[edit | edit source]

Literature[edit | edit source]

  • ALBERTS, Bruce. Molecular Biology of the Cell. 6. edition. New York : Garland Science, 2015. 338–355 pp. ISBN 978-0-8153-3218-3.
  • BERG, Jeremy M. – TYMOCZKO, John L.. Biochemistry. 8. edition. New York : W.H. Freeman, 2015. 817–830 pp. ISBN 978-1-4641-2610-7.